MENU
TGTX
AS OF
Feb 4, 03:36 PM (EDT)
Price
$29.24
Change
-$0.49 (-1.65%)
Capitalization
4.72B
27 days until earnings call
Intraday BUY SELL Signals
+Compare
TGTX
Stock ticker: NASDAQ
AS OF
Feb 4, 03:36 PM (EDT)
Price
$29.24
Change
-$0.49 (-1.65%)
Capitalization
4.72B

TGTX TG Therapeutics Forecast, Technical & Fundamental Analysis

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TGTX with price predictions
Feb 03, 2026

TGTX in upward trend: price expected to rise as it breaks its lower Bollinger Band on January 09, 2026

TGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where TGTX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TGTX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TGTX as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TGTX turned negative on February 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

TGTX moved below its 50-day moving average on January 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TGTX crossed bearishly below the 50-day moving average on January 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TGTX entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TGTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.776) is normal, around the industry mean (27.519). P/E Ratio (10.740) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (9.042) is also within normal values, averaging (331.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TGTX is expected to report earnings to fall 84.78% to 36 cents per share on March 03

TG Therapeutics TGTX Stock Earnings Reports
Q4'25
Est.
$0.37
Q3'25
Beat
by $2.21
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.07
The last earnings report on November 03 showed earnings per share of $2.43, beating the estimate of 21 cents. With 97.76K shares outstanding, the current market capitalization sits at 4.72B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGIIX86.771.08
+1.26%
First Eagle Global I
FVDFX40.51N/A
N/A
Fidelity Value Discovery
ABWCX15.52-0.04
-0.26%
AB All Market Total Return C
GSMQX17.37-0.10
-0.57%
Goldman Sachs Small/Mid Cap Growth Svc
RMBJX23.87-0.47
-1.93%
RMB C

TGTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with PTCT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then PTCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.88%
PTCT - TGTX
41%
Loosely correlated
-0.07%
KRYS - TGTX
40%
Loosely correlated
-0.96%
ARRY - TGTX
36%
Loosely correlated
+1.71%
CLLS - TGTX
36%
Loosely correlated
-7.59%
AXON - TGTX
36%
Loosely correlated
-1.89%
More